Source: Eur Respir Mon; 2009: 46: 386–395



Rating:

Share or cite this content

Citations should be made in the following way:
T. Leong, M. Conron. Clinical use of interstitial lung disease guidelines. Eur Respir Mon; 2009: 46: 386–395

Member's Comments

No comment yet.

Related content which might interest you: Clinical trials in interstitial lung disease Source: Eur Respir Mon; 2009: 46: 67–84 Year: 2009 Clinical characteristics of anti-Jo-1-positive interstitial lung disease Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Clinical pitfalls in diagnosing interstitial lung disease Source: International Congress 2014 – PG02 Current clinical problems in pulmonology Year: 2014 Clinical study of pediatric interstitial lung diseases in China Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Evidence-based consensus recommendations for the identification and management of interstitial lung disease in systemic sclerosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Can current guidelines improve the diagnosis of a usual interstitial pneumonia among general radiologists? Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations Source: ERS webinar 2020: COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations Year: 2020 A pragmatic clinical classification for interstitial lung disease Source: Annual Congress 2012 - Reclassification of idiopathic interstitial pneumonias Year: 2012 Clinical significance of autoantibody screening in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Paediatric interstitial lung disease Source: Eur Respir Mon; 2009: 46: 319–354 Year: 2009 Paediatric interstitial lung disease Source: ERS Course 2016 Year: 2016 ERS guidelines on treatment of sarcoidosis Source: ERS webinar 2021: ERS guidelines on treatment of sarcoidosis Year: 2021 Clinical management implications of histologic information provided by lung biopsy in the multidisciplinary evaluation of interstitial lung diseases. Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases) Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Assessment of fibrosis in lung biopsies from the European childhood interstitial lung disease (chILD) registry Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT Source: International Congress 2016 – Clinical aspects of ILD Year: 2016